| Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial I Olivotto, A Oreziak, R Barriales-Villa, TP Abraham, A Masri, ... The Lancet 396 (10253), 759-769, 2020 | 686 | 2020 |
| Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation SA Haji, RC Starling, RK Avery, S Mawhorter, EM Tuzcu, P Schoenhagen, ... The Journal of heart and lung transplantation 23 (3), 277-283, 2004 | 146 | 2004 |
| Mavacamten favorably impacts cardiac structure in obstructive hypertrophic cardiomyopathy: EXPLORER-HCM cardiac magnetic resonance substudy analysis S Saberi, N Cardim, M Yamani, J Schulz-Menger, W Li, V Florea, ... Circulation 143 (6), 606-608, 2021 | 137 | 2021 |
| Chemokine and chemokine receptor gene expression indicates acute rejection of human cardiac transplants1 NM Fahmy, MH Yamani, RC Starling, NB Ratliff, JB Young, PM McCarthy, ... Transplantation 75 (1), 72-78, 2003 | 132 | 2003 |
| Improved survival after acute myocardial infarction complicated by cardiogenic shock with circulatory support and transplantation: comparing aggressive intervention with … W Tayara, RC Starling, MH Yamani, O Wazni, F Jubran, N Smedira The Journal of heart and lung transplantation 25 (5), 504-509, 2006 | 117 | 2006 |
| Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: hemodynamic efficacy, clinical outcome, and economic impact MH Yamani, SA Haji, RC Starling, L Kelly, N Albert, DL Knack, JB Young American heart journal 142 (6), 998-1002, 2001 | 114 | 2001 |
| Molecular testing in the management of cardiac transplant recipients: initial clinical experience RC Starling, M Pham, H Valantine, L Miller, H Eisen, ER Rodriguez, ... The Journal of heart and lung transplantation 25 (12), 1389-1395, 2006 | 112 | 2006 |
| The impact of routine mycophenolate mofetil drug monitoring on the treatment of cardiac allograft rejection MH Yamani, RC Starling, M Goormastic, F Van Lente, N Smedira, ... Transplantation 69 (11), 2326-2330, 2000 | 104 | 2000 |
| Hypogammaglobulinemia and infection risk in solid organ transplant recipients S Mawhorter, MH Yamani Current opinion in organ transplantation 13 (6), 581-585, 2008 | 93 | 2008 |
| Myocardial ischemic-fibrotic injury after human heart transplantation is associated with increased progression of vasculopathy, decreased cellular rejection and poor long-term … MH Yamani, SA Haji, RC Starling, EM Tuzcu, NB Ratliff, DJ Cook, A Abdo, ... Journal of the American College of Cardiology 39 (6), 970-977, 2002 | 87 | 2002 |
| Hypogammaglobulinemia following cardiac transplantation: a link between rejection and infection MH Yamani, RK Avery, SD Mawhorter, JB Young, NB Ratliff, RE Hobbs, ... The Journal of heart and lung transplantation 20 (4), 425-430, 2001 | 86 | 2001 |
| Congestive heart failure: insights from epidemiology, implications for treatment M Yamani, BM Massie Mayo Clinic Proceedings 68 (12), 1214-1218, 1993 | 83 | 1993 |
| The effect of combined angiotensin-converting enzyme inhibition and calcium antagonism on allograft coronary vasculopathy validated by intravascular ultrasound K Erinc, MH Yamani, RC Starling, T Crowe, R Hobbs, C Bott-Silverman, ... The Journal of heart and lung transplantation 24 (8), 1033-1038, 2005 | 79 | 2005 |
| Chemokine and receptor-gene expression during early and late acute rejection episodes in human cardiac allografts NM Fahmy, MH Yamani, RC Starling, NB Ratliff, JB Young, PM McCarthy, ... Transplantation 75 (12), 2044-2047, 2003 | 77 | 2003 |
| Cellular rejection and rate of progression of transplant vasculopathy: a 3-year serial intravascular ultrasound study J Jimenez, SR Kapadia, MH Yamani, L Platt, RE Hobbs, G Rincon, ... The Journal of heart and lung transplantation 20 (4), 393-398, 2001 | 72 | 2001 |
| Encephalitis owing to human herpesvirus-6 after cardiac transplant PJ Nash, RK Avery, WHW Tang, RC Starling, AJ Taege, MH Yamani American Journal of Transplantation 4 (7), 1200-1203, 2004 | 70 | 2004 |
| Peritransplant ischemic injury is associated with up-regulation of stromal cell-derived factor-1 MH Yamani, NB Ratliff, DJ Cook, EM Tuzcu, Y Yu, R Hobbs, G Rincon, ... Journal of the American College of Cardiology 46 (6), 1029-1035, 2005 | 68 | 2005 |
| Hypogammaglobulinemia after heart transplantation: impact of pre‐emptive use of immunoglobulin replacement (CytoGam®) on infection and rejection outcomes MH Yamani, R Avery, S Mawhorter, JB Young, A McNeill, DJ Cook, ... Transplant Infectious Disease 3, 40-43, 2001 | 63 | 2001 |
| Thymoglobulin induction and steroid avoidance in cardiac transplantation: results of a prospective, randomized, controlled study MH Yamani, DO Taylor, J Czerr, C Haire, R Kring, L Zhou, R Hobbs, ... Clinical transplantation 22 (1), 76-81, 2008 | 62 | 2008 |
| Does acute cellular rejection correlate with cardiac allograft vasculopathy? MH Yamani, M Yousufuddin, RC Starling, M Tuzcu, NB Ratliff, DJ Cook, ... The Journal of heart and lung transplantation 23 (3), 272-276, 2004 | 61 | 2004 |
